impacting

TCG World Proudly Announces Partnership With STYNGR & Downtown

In partnership with STYNGR, XRP Ledger, and the iconic Downtown is set to launch music digital collectibles in Q2 2024 featuring artist exclusives, in-world activations, and more LOS ANGELES, April 10, 2024 – The virtual realm will soon pulse to the rhythm of music. TCG World, the fast-growing and immersive Web3 online open world metaverse, today announced a groundbreaking partnership with STYNGR, the premier music integration platform for the gaming ecosystem, and Downtown, one of the most dominant forces in the music industry. In a move set to revolutionize the

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced